Article Versions Notes

Hu S, Li S, Cui Y, Wang Y, Chen L, Zhang X, Hou L, Feng L. Integrative Multi-Omics Analysis Identifies IL18R1 as a Circulating Prognostic Biomarker for Risk Stratification in Extensive-Stage Small Cell Lung Cancer. Cancers. 2026; 18(10):1608. https://doi.org/10.3390/cancers18101608

Hu, Shengjuan, Sicong Li, Yiyuan Cui, Ying Wang, Luyao Chen, Xiyuan Zhang, Li Hou, and Li Feng. 2026. "Integrative Multi-Omics Analysis Identifies IL18R1 as a Circulating Prognostic Biomarker for Risk Stratification in Extensive-Stage Small Cell Lung Cancer" Cancers 18, no. 10: 1608. https://doi.org/10.3390/cancers18101608

Hu, S., Li, S., Cui, Y., Wang, Y., Chen, L., Zhang, X., Hou, L., & Feng, L. (2026). Integrative Multi-Omics Analysis Identifies IL18R1 as a Circulating Prognostic Biomarker for Risk Stratification in Extensive-Stage Small Cell Lung Cancer. Cancers, 18(10), 1608. https://doi.org/10.3390/cancers18101608